![Doros Platika](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Doros Platika
Directeur Général chez
Supercentenarian Research Foundation
Profil
Doros Platika is currently the President & Chief Executive Officer at the Supercentenarian Research Foundation and a Director at WorldCare, Inc. He previously served as President & Chief Executive Officer at Curis, Inc., Ontogeny, Inc., Centagenetix, Inc., and Pittsburgh Life Sciences Green House.
He was also a Director at V.I.
Technologies, Inc. and Cohera Medical, Inc. In addition, he held the position of Executive Vice President-Research & Development at Progenitor, Inc. Dr. Platika received his undergraduate degree from The Reed Institute and his doctorate from Stony Brook University.
Postes actifs de Doros Platika
| Sociétés | Poste | Début |
|---|---|---|
Supercentenarian Research Foundation | Directeur Général | - |
WorldCare, Inc. (Massachusetts)
 WorldCare, Inc. (Massachusetts) Medical/Nursing ServicesHealth Services Develops and commercializes global healthcare services and solutions | Directeur/Membre du Conseil | - |
Anciens postes connus de Doros Platika
| Sociétés | Poste | Fin |
|---|---|---|
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Directeur/Membre du Conseil | 11/03/2005 |
| CURIS, INC. | Directeur Général | 01/09/2001 |
Progenitor, Inc.
 Progenitor, Inc. BiotechnologyHealth Technology Develops pharmaceutical compounds for nervous system | Directeur Technique/Scientifique/R&D | - |
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | President | - |
Centagenetix, Inc.
 Centagenetix, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics to slow the aging process | President | - |
Formation de Doros Platika
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Develops pharmaceutical compounds for nervous system | Health Technology |
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Cohera Medical, Inc.
 Cohera Medical, Inc. Medical SpecialtiesHealth Technology Develops surgical adhesives and sealants | Health Technology |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Health Technology |
Centagenetix, Inc.
Centagenetix, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics to slow the aging process | Commercial Services |
The Reed Institute
 The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WorldCare, Inc. (Massachusetts)
WorldCare, Inc. (Massachusetts) Medical/Nursing ServicesHealth Services Develops and commercializes global healthcare services and solutions | Health Services |
Pittsburgh Life Sciences Green House
 Pittsburgh Life Sciences Green House Investment ManagersFinance PLSG invests in companies located in the United States, primarily in Western Pennsylvania. The firm focuses on the life sciences sector. It provides financing for seed, early and growth stage capital requirements. | Finance |
Supercentenarian Research Foundation |
Choisissez Zonebourse 
